New Shot-in-the-Arm cancer drug tested in Real-World study
NCT ID NCT07562347
First seen May 03, 2026 · Last updated May 18, 2026 · Updated 3 times
Summary
This study tracks the safety and effectiveness of envafolimab, a cancer drug given as a quick shot under the skin, in 120 adults with advanced solid tumors. It aims to see how well the drug controls tumors and extends life in everyday medical practice, not just in controlled trials. Participants must have already tried standard treatments and be enrolled through a special access program.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.